Aurobindo Pharma Ltd
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|
| Revenue | 3,041.40 | 3,000.64 | 2,877.43 |
| Operating Expense | 1,917.26 | 2,005.13 | 1,975.18 |
| Net Profit | 737.22 | 692.23 | 582.07 |
| Net Profit Margin | 24.24% | 23.07% | 20.23% |
| Earning Per Share | 12.75 | 11.92 | 10.02 |
| EBIDTA | 1,124.78 | 993.38 | 905.39 |
| Effective Tax Rate | 24.15% | 18.28% | 22.50% |
Particulars
Jun 2026
Revenue3,041.40
Operating Expense1,917.26
Net Profit737.22
Net Profit Margin24.24
Earning Per Share12.75
EBIDTA1,124.78
Effective Tax Rate24.15
